Computational discovery of lead compounds targeting G1202R-based ALK triple mutations conferring lorlatinib resistance in EML4-ALK variant 3 non-small cell lung cancer. - Bharath, Palani; Vignesh, Sivaprakasam; D., Thirumal Kumar (Journal of Applied Pharmaceutical Science, 2026)